Root-Bernstein Robert
Department of Physiology, 2174 Biomedical and Physical Sciences Building, Michigan State University, East Lansing, MI 48824, USA.
Vaccine. 2005 Mar 18;23(17-18):2160-3. doi: 10.1016/j.vaccine.2005.01.049.
HIV proteins mimic HLA proteins, and the proteins of cofactor infections (cytomegalovirus, hepatitis viruses, mycobacteria, mycoplasmas) mimic CD4 proteins, making some HIV antigens molecularly complementary to cofactor antigens. Antibodies to HIV and its cofactors should therefore act like idiotype-antiidiotype pairs. Over 2000 combinations of antibodies were tested for such complementarity using modified forms of Ouchterlony immunodiffusion and ELISA. HIV antibodies do precipitate some antibodies against cofactor infections including CMV, HBV, mycobacteria and mycoplasmas. These antibodies also mimic antibodies against HLA and CD4 proteins. Thus, some combinations of HIV with cofactor infections may induce lymphocytotoxic antibodies (LCTA), a risk that must be addressed in vaccine development.
HIV蛋白模仿HLA蛋白,而辅助因子感染(巨细胞病毒、肝炎病毒、分枝杆菌、支原体)的蛋白模仿CD4蛋白,使得一些HIV抗原在分子上与辅助因子抗原互补。因此,针对HIV及其辅助因子的抗体应表现得像独特型-抗独特型对。使用改良形式的双向免疫扩散和酶联免疫吸附测定法对2000多种抗体组合进行了这种互补性测试。HIV抗体确实沉淀了一些针对包括巨细胞病毒、乙肝病毒、分枝杆菌和支原体在内的辅助因子感染的抗体。这些抗体也模仿针对HLA和CD4蛋白的抗体。因此,HIV与辅助因子感染的某些组合可能会诱导淋巴细胞毒性抗体(LCTA),这是疫苗开发中必须解决的一个风险。